Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 5/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.52 |
| ▸ | CX3CR1 | P49238 | 12/20 | 0.40 |
| ▸ | CXCR2 | P25025 | 11/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.38 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6216000 | 0.82 | MEN1 (0.46) | ADORA1ADORA2AADORA3ADORA2B | |
| SCHEMBL5774908 | 0.79 | CXCR2 (0.35) | ADORA1ADORA2ACX3CR1CXCR2ADORA3 | |
| SCHEMBL5774915 | 0.79 | CXCR2 (0.35) | ADORA1ADORA2ACX3CR1CXCR2ADORA3 | |
| Hydrochloric Acid SCHEMBL5776728 | 0.74 | PDE5A (0.44) | ADORA1ADORA2AADORA3 | |
| Hydrochloric Acid SCHEMBL5776353 | 0.73 | NPY5R (0.46) | ADORA1ADORA2AADORA3 | |
| SCHEMBL5772035 | 0.72 | NPY5R (0.58) | ADORA1ADORA2A | |
| SCHEMBL5771208 | 0.71 | KDM4E (0.39) | ADORA1ADORA2AADORA3 | |
| SCHEMBL8115271 | 0.71 | GBA1 (0.40) | ADORA1ADORA2AADORA3CNR1 | |
| SCHEMBL5773067 | 0.71 | F10 (0.39) | ADORA1ADORA2A | |
| SCHEMBL5774513 | 0.70 | HIF1A (0.49) | ADORA1ADORA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1054887-B1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2006-04-12 | — | — | EP | disclosed |
| US-6583154-B1 | Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines | AMGEN INC. | 2003-06-24 | — | — | US | disclosed |
| US-6187777-B1 | PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS | AMGEN INC. | 2001-02-13 | — | — | US | disclosed |
| EP-1054887-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | Amgen Inc. (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999040091-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC. (US) | 1999-08-12 | — | — | WO | disclosed |